2565 NW Lovejoy St. Suite 200 Portland, OR 97210
Phone: 503-226-3376
Fax: 503-223-9561

.

IMPORTANT- Masking is now optional, but encouraged.

We are now accepting payments online through our patient portal.

flower_banner

Acne Publications

Click on the title to see the full article:

A long-term safety and efficacy study of trifarotene 50µg g cream in subjects with facial and truncal acne

A Multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance therapy

A Randomized, Parallel, Vehicle-Controlled Comparison of Two Erythromycin Benzoyl Peroxide Preparations for Acne Vulgaris

A triple combination agent in the treatment of melasma

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris

Assessing efficacy of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) in aqueous gel in moderate of severe acne subpopulations

Assessing efficacy of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) in aqueous gel in the treatment of severe acne

Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne

Hormonal Contraceptives for Acne Management

Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea

Oregon Dermatology & Research Center - 2565 NW Lovejoy St., Portland, OR, 97210 - (503) 226-3376.